Correlation Between YuantaP Shares and Lotus Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both YuantaP Shares and Lotus Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining YuantaP Shares and Lotus Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between YuantaP shares Taiwan Mid Cap and Lotus Pharmaceutical Co, you can compare the effects of market volatilities on YuantaP Shares and Lotus Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in YuantaP Shares with a short position of Lotus Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of YuantaP Shares and Lotus Pharmaceutical.

Diversification Opportunities for YuantaP Shares and Lotus Pharmaceutical

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between YuantaP and Lotus is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding YuantaP shares Taiwan Mid Cap and Lotus Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lotus Pharmaceutical and YuantaP Shares is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on YuantaP shares Taiwan Mid Cap are associated (or correlated) with Lotus Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lotus Pharmaceutical has no effect on the direction of YuantaP Shares i.e., YuantaP Shares and Lotus Pharmaceutical go up and down completely randomly.

Pair Corralation between YuantaP Shares and Lotus Pharmaceutical

Assuming the 90 days trading horizon YuantaP shares Taiwan Mid Cap is expected to under-perform the Lotus Pharmaceutical. But the etf apears to be less risky and, when comparing its historical volatility, YuantaP shares Taiwan Mid Cap is 1.86 times less risky than Lotus Pharmaceutical. The etf trades about -0.03 of its potential returns per unit of risk. The Lotus Pharmaceutical Co is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  28,900  in Lotus Pharmaceutical Co on September 1, 2024 and sell it today you would earn a total of  250.00  from holding Lotus Pharmaceutical Co or generate 0.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.22%
ValuesDaily Returns

YuantaP shares Taiwan Mid Cap  vs.  Lotus Pharmaceutical Co

 Performance 
       Timeline  
YuantaP shares Taiwan 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days YuantaP shares Taiwan Mid Cap has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, YuantaP Shares is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Lotus Pharmaceutical 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Lotus Pharmaceutical Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Lotus Pharmaceutical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

YuantaP Shares and Lotus Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with YuantaP Shares and Lotus Pharmaceutical

The main advantage of trading using opposite YuantaP Shares and Lotus Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if YuantaP Shares position performs unexpectedly, Lotus Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lotus Pharmaceutical will offset losses from the drop in Lotus Pharmaceutical's long position.
The idea behind YuantaP shares Taiwan Mid Cap and Lotus Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal